Home › Companies › Fulgent Genetics, Inc. › 2025-2026

Fulgent Genetics, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Fulgent Genetics, Inc.’s Form 8-K, filed May 14, 2026 (Item 5.07 on EDGAR). Page generated October 18, 2026.

7Ballot items
210Asset managers
1,450Fund votes
May 14, 2026Meeting date

Results at a glance

Meeting of May 14, 2026: 7 items on Fulgent Genetics, Inc.’s Form 8-K, filed May 14, 2026: 7 without a stated outcome.

Material dissent

Elect Director: Linda Dong 76% of votes cast Outcome not stated Director under 80%
Elect Director: Michael Nohaile, Ph.D. 78% of votes cast Outcome not stated Director under 80%
Elect Director: Regina Groves 73% of votes cast Outcome not stated Director under 80%

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Fulgent Genetics, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Fulgent Genetics, Inc.

These tallies are Fulgent Genetics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 14, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Fulgent Genetics, Inc. — official shareholder meeting results, meeting held May 14, 2026
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Ming Hsieh	21,979,668	--	--	276,275	2,323,053	99%	Not verified	—
Elect Director: Linda Dong	16,836,781	--	--	5,419,162	2,323,053	76%	Not verified	—
Elect Director: Michael Nohaile, Ph.D.	17,258,629	--	--	4,997,314	2,323,053	78%	Not verified	—
Elect Director: Regina Groves	16,240,666	--	--	6,015,277	2,323,053	73%	Not verified	—
2. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026	24,470,414	87,192	21,390	--	--	99.6%	Not verified	—
3. Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers	19,800,226	2,410,239	45,478	--	2,323,053	89%	Not verified	—
4. Approval of the Company's 2026 Equity Incentive Plan	18,693,758	3,513,983	48,202	--	2,323,053	84%	Not verified	—

Source: Fulgent Genetics, Inc., Form 8-K, filed with the SEC on May 14, 2026 — read the filing on EDGAR.

How asset managers voted at the Fulgent Genetics, Inc. 2025-2026 meeting

Each item below shows how the 210 asset managers that disclosed a Fulgent Genetics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Linda Dong

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

76% Majority: yes · of votes cast

FOR 76%WITHHELD

FOR: 16,836,781WITHHELD: 5,419,162

Details: description as filed, official tally, votes by 55 asset managers

Description as filed by funds: Election of Directors: Linda Dong

Fulgent Genetics, Inc.’s own tally for this item (“Elect Director: Linda Dong”): 16,836,781 for, 5,419,162 withheld, per its Form 8-K filed May 14, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 76% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 55 asset managers below reported 2,384,737 for, 2,378,782 withheld, 8 abstained.

FORWITHHOLD

FOR: 2,384,737ABSTAIN: 8WITHHOLD: 2,378,782

Largest asset managers voting on “Election of Directors: Linda Dong” at Fulgent Genetics, Inc., 2025-2026
Asset manager	For	Abstain	Withheld	Vote
BlackRock	0	0	1,167,126	Withhold
Vanguard	1,096,039	8	0	For
Fidelity	484,877	0	95,305	Mixed
Columbia Threadneedle	0	0	508,854	Withhold
Charles Schwab	405,573	0	0	For
TIAA	144,282	0	0	For
PIMCO	0	0	124,279	Withhold
Nationwide	0	0	76,461	Withhold
Dimensional	71,453	0	0	For
American Century	0	0	53,949	Withhold
Federated Hermes	0	0	49,207	Withhold
GuideStone	0	0	45,160	Withhold
Equitable	0	0	42,001	Withhold
QUANTITATIVE MASTER SERIES LLC	0	0	34,731	Withhold
Lincoln Financial	18,423	0	13,415	Mixed
JPMorgan	0	0	31,219	Withhold
ALPS ETF Trust	0	0	27,554	Withhold
State Street	27,316	0	62	For
Russell Investments	23,479	0	0	For
Goldman Sachs	23,253	0	0	For
MASTER INVESTMENT PORTFOLIO	0	0	23,208	Withhold
NORTHERN LIGHTS FUND TRUST III	19,250	0	0	For
Global X	18,571	0	0	For
Invesco	16,941	0	0	For
AIG/SunAmerica	0	0	13,986	Withhold

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

2. Elect Director: Michael Nohaile, Ph.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

78% Majority: yes · of votes cast

FOR 78%WITHHELD

FOR: 17,258,629WITHHELD: 4,997,314

Details: description as filed, official tally, votes by 55 asset managers

Description as filed by funds: Election of Directors: Michael Nohaile, Ph.D.

Fulgent Genetics, Inc.’s own tally for this item (“Elect Director: Michael Nohaile, Ph.D.”): 17,258,629 for, 4,997,314 withheld, per its Form 8-K filed May 14, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 78% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 55 asset managers below reported 2,688,240 for, 2,075,279 withheld, 8 abstained.

FORWITHHOLD

FOR: 2,688,240ABSTAIN: 8WITHHOLD: 2,075,279

Largest asset managers voting on “Election of Directors: Michael Nohaile, Ph.D.” at Fulgent Genetics, Inc., 2025-2026
Asset manager	For	Abstain	Withheld	Vote
BlackRock	850,102	0	317,024	Mixed
Vanguard	1,093,506	8	2,533	For
Fidelity	493,465	0	86,717	Mixed
Columbia Threadneedle	0	0	508,854	Withhold
Charles Schwab	0	0	405,573	Withhold
TIAA	0	0	144,282	Withhold
PIMCO	0	0	124,279	Withhold
Nationwide	577	0	75,884	Withhold
Dimensional	71,453	0	0	For
American Century	0	0	53,949	Withhold
Federated Hermes	0	0	49,207	Withhold
GuideStone	0	0	45,160	Withhold
Equitable	29,541	0	12,460	Mixed
QUANTITATIVE MASTER SERIES LLC	34,731	0	0	For
Lincoln Financial	18,423	0	13,415	Mixed
JPMorgan	0	0	31,219	Withhold
ALPS ETF Trust	0	0	27,554	Withhold
State Street	27,313	0	65	For
Russell Investments	0	0	23,479	Withhold
Goldman Sachs	23,253	0	0	For
MASTER INVESTMENT PORTFOLIO	0	0	23,208	Withhold
NORTHERN LIGHTS FUND TRUST III	0	0	19,250	Withhold
Global X	0	0	18,571	Withhold
Invesco	0	0	16,941	Withhold
AIG/SunAmerica	0	0	13,986	Withhold

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

3. Elect Director: Ming Hsieh

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 21,979,668WITHHELD: 276,275

Details: description as filed, official tally, votes by 55 asset managers

Description as filed by funds: Election of Directors: Ming Hsieh

Fulgent Genetics, Inc.’s own tally for this item (“Elect Director: Ming Hsieh”): 21,979,668 for, 276,275 withheld, per its Form 8-K filed May 14, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 55 asset managers below reported 4,749,388 for, 14,139 withheld.

FOR

FOR: 4,749,388WITHHOLD: 14,139

Largest asset managers voting on “Election of Directors: Ming Hsieh” at Fulgent Genetics, Inc., 2025-2026
Asset manager	For	Withheld	Vote
BlackRock	1,167,126	0	For
Vanguard	1,096,047	0	For
Fidelity	580,182	0	For
Columbia Threadneedle	508,854	0	For
Charles Schwab	405,573	0	For
TIAA	144,282	0	For
PIMCO	124,279	0	For
Nationwide	76,461	0	For
Dimensional	71,453	0	For
American Century	53,949	0	For
Federated Hermes	49,207	0	For
GuideStone	45,160	0	For
Equitable	29,541	12,460	Mixed
QUANTITATIVE MASTER SERIES LLC	34,731	0	For
Lincoln Financial	31,838	0	For
JPMorgan	31,219	0	For
ALPS ETF Trust	27,554	0	For
State Street	27,378	0	For
Russell Investments	23,479	0	For
Goldman Sachs	23,253	0	For
MASTER INVESTMENT PORTFOLIO	23,208	0	For
NORTHERN LIGHTS FUND TRUST III	19,250	0	For
Global X	18,571	0	For
Invesco	16,941	0	For
AIG/SunAmerica	13,986	0	For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

4. Elect Director: Regina Groves

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

73% Majority: yes · of votes cast

FOR 73%WITHHELD

FOR: 16,240,666WITHHELD: 6,015,277

Details: description as filed, official tally, votes by 55 asset managers

Description as filed by funds: Election of Directors: Regina Groves

Fulgent Genetics, Inc.’s own tally for this item (“Elect Director: Regina Groves”): 16,240,666 for, 6,015,277 withheld, per its Form 8-K filed May 14, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 73% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 55 asset managers below reported 2,180,868 for, 2,582,650 withheld, 9 abstained.

FORWITHHOLD

FOR: 2,180,868ABSTAIN: 9WITHHOLD: 2,582,650

Largest asset managers voting on “Election of Directors: Regina Groves” at Fulgent Genetics, Inc., 2025-2026
Asset manager	For	Abstain	Withheld	Vote
BlackRock	0	0	1,167,126	Withhold
Vanguard	1,096,038	9	0	For
Fidelity	484,877	0	95,305	Mixed
Columbia Threadneedle	0	0	508,854	Withhold
Charles Schwab	405,573	0	0	For
TIAA	0	0	144,282	Withhold
PIMCO	0	0	124,279	Withhold
Nationwide	0	0	76,461	Withhold
Dimensional	71,453	0	0	For
American Century	0	0	53,949	Withhold
Federated Hermes	0	0	49,207	Withhold
GuideStone	0	0	45,160	Withhold
Equitable	0	0	42,001	Withhold
QUANTITATIVE MASTER SERIES LLC	0	0	34,731	Withhold
Lincoln Financial	4,023	0	27,815	Mixed
JPMorgan	0	0	31,219	Withhold
ALPS ETF Trust	0	0	27,554	Withhold
State Street	29	0	27,349	Withhold
Russell Investments	23,479	0	0	For
Goldman Sachs	23,253	0	0	For
MASTER INVESTMENT PORTFOLIO	0	0	23,208	Withhold
NORTHERN LIGHTS FUND TRUST III	19,250	0	0	For
Global X	18,571	0	0	For
Invesco	0	0	16,941	Withhold
AIG/SunAmerica	0	0	13,986	Withhold

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

5. 4. Approval of the Company's 2026 Equity Incentive Plan

Outcome not verifiedCOMPENSATIONReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%AGAINST

FOR: 18,693,758AGAINST: 3,513,983

Details: description as filed, official tally, votes by 55 asset managers

Description as filed by funds: To approve the Company's 2026 Equity Incentive Plan.

Fulgent Genetics, Inc.’s own tally for this item (“4. Approval of the Company's 2026 Equity Incentive Plan”): 18,693,758 for, 3,513,983 against, per its Form 8-K filed May 14, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 84% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 55 asset managers below reported 4,020,684 for, 745,849 against.

FORAGAINST

FOR: 4,020,684AGAINST: 745,849

Largest asset managers voting on “To approve the Company's 2026 Equity Incentive Plan.” at Fulgent Genetics, Inc., 2025-2026
Asset manager	For	Against	Vote
BlackRock	1,167,126	0	For
Vanguard	1,094,325	1,722	For
Fidelity	493,465	86,717	Mixed
Columbia Threadneedle	508,854	0	For
Charles Schwab	405,573	0	For
TIAA	0	144,282	Against
PIMCO	0	124,279	Against
Nationwide	577	75,884	Against
Dimensional	0	71,453	Against
American Century	53,949	0	For
Federated Hermes	49,207	0	For
GuideStone	0	45,160	Against
Equitable	29,541	12,460	Mixed
QUANTITATIVE MASTER SERIES LLC	34,731	0	For
Lincoln Financial	0	31,838	Against
JPMorgan	31,219	0	For
ALPS ETF Trust	0	27,554	Against
State Street	26	27,352	Against
Russell Investments	23,479	0	For
Goldman Sachs	23,253	0	For
MASTER INVESTMENT PORTFOLIO	23,208	0	For
NORTHERN LIGHTS FUND TRUST III	0	19,250	Against
Global X	18,571	0	For
Invesco	16,941	0	For
AIG/SunAmerica	0	13,986	Against

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

6. 3. Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers

Outcome not verified Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 7 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%

FOR: 19,800,226AGAINST: 2,410,239

Details: description as filed, official tally, votes by 182 asset managers

Description as filed by funds: To approve, on an advisory basis, compensation awarded to the Company's named executive officers (Say-on-Pay).

Fulgent Genetics, Inc.’s own tally for this item (“3. Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers”): 19,800,226 for, 2,410,239 against, per its Form 8-K filed May 14, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Fulgent Genetics, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “To approve by an advisory vote the compensation of our named executive officers, as disclosed in this proxy statement.” (30 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 47 asset managers voting on “To approve, on an advisory basis, compensation awarded to the Company's named executive officers (Say-on-Pay).” at Fulgent Genetics, Inc., 2025-2026
Asset manager	For	Against	Vote
BlackRock	1,167,126	0	For
Vanguard	1,093,936	3	For
Fidelity	580,182	0	For
Columbia Threadneedle	0	508,854	Against
TIAA	144,282	0	For
PIMCO	124,279	0	For
Nationwide	76,461	0	For
Dimensional	0	71,453	Against
American Century	53,949	0	For
GuideStone	45,160	0	For
Equitable	42,001	0	For
QUANTITATIVE MASTER SERIES LLC	34,731	0	For
Lincoln Financial	27,815	4,023	Mixed
JPMorgan	31,219	0	For
ALPS ETF Trust	27,554	0	For
State Street	27,333	45	For
Goldman Sachs	23,253	0	For
MASTER INVESTMENT PORTFOLIO	23,208	0	For
NORTHERN LIGHTS FUND TRUST III	19,250	0	For
Invesco	16,941	0	For
AIG/SunAmerica	13,986	0	For
Northern Trust	13,696	0	For
Brighthouse	12,120	0	For
Jackson National	4,138	7,469	Mixed
Bridge Builder Trust	8,999	0	For

Fund voting reports, all 47 managers: 3,659,010 for, 599,303 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 150 asset managers voting on “To approve, on an advisory basis, compensation awarded to the Company's named executive officers (Say-on-Pay).” at Fulgent Genetics, Inc., 2025-2026
Asset manager	For	Against	Vote
RTW INVESTMENTS, LP	1,289,000	0	For
BlackRock	1,095,128	5,585	For
ACADIAN ASSET MANAGEMENT LLC	752,353	0	For
GEODE CAPITAL MANAGEMENT, LLC	556,681	0	For
State Street	410,946	3,965	For
Connor, Clark & Lunn Investment Management Ltd.	179,433	0	For
JACOBS LEVY EQUITY MANAGEMENT, INC	165,521	0	For
Vanguard	156,125	0	For
Peapod Lane Capital LLC	145,474	0	For
Nuveen	145,114	0	For
Two Sigma	134,066	0	For
Northern Trust	116,181	2,372	For
Portolan Capital Management, LLC	106,642	0	For
UBS	0	97,121	Against
Dimensional	0	94,896	Against
LEVIN CAPITAL STRATEGIES, L.P.	60,496	0	For
American Century	54,122	0	For
AMERIPRISE FINANCIAL INC	46	53,735	Against
T. Rowe Price	46,022	0	For
Maryland State Retirement & Pension System	0	44,265	Against
Amundi	0	41,596	Against
PACIFIC INVESTMENT MANAGEMENT CO LLC	40,243	0	For
EASTERLY INVESTMENT PARTNERS LLC	39,023	0	For
ENVESTNET ASSET MANAGEMENT INC	0	36,287	Against
MELLON INVESTMENTS Corp	36,273	0	For

Institutional-manager reports, all 150 managers: 5,809,541 for, 428,769 against, 9,389 abstained, 188 not voted. Showing the 25 largest; see all in the interactive database.

7. 2. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting…

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%

FOR: 24,470,414AGAINST: 87,192

Details: description as filed, official tally, votes by 55 asset managers

Description as filed by funds: To ratify the appointment of Deloitte & Touche LLP as the Company's Independent registered public accounting firm for the fiscal year ending December 31, 2026.

Fulgent Genetics, Inc.’s own tally for this item (“2. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 24,470,414 for, 87,192 against, per its Form 8-K filed May 14, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 55 asset managers below reported 4,763,527 for.

FOR

FOR: 4,763,527

Largest asset managers voting on “To ratify the appointment of Deloitte & Touche LLP as the Company's Independent registered public accounting f” at Fulgent Genetics, Inc., 2025-2026
Asset manager	For	Vote
BlackRock	1,167,126	For
Vanguard	1,096,047	For
Fidelity	580,182	For
Columbia Threadneedle	508,854	For
Charles Schwab	405,573	For
TIAA	144,282	For
PIMCO	124,279	For
Nationwide	76,461	For
Dimensional	71,453	For
American Century	53,949	For
Federated Hermes	49,207	For
GuideStone	45,160	For
Equitable	42,001	For
QUANTITATIVE MASTER SERIES LLC	34,731	For
Lincoln Financial	31,838	For
JPMorgan	31,219	For
ALPS ETF Trust	27,554	For
State Street	27,378	For
Russell Investments	23,479	For
Goldman Sachs	23,253	For
MASTER INVESTMENT PORTFOLIO	23,208	For
NORTHERN LIGHTS FUND TRUST III	19,250	For
Global X	18,571	For
Invesco	16,941	For
AIG/SunAmerica	13,986	For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

Largest Fulgent Genetics, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 28,400,623 shares outstanding at the time of that meeting.

Fund voting reports: top Fulgent Genetics, Inc. shareholders by shares voted on “Election of Directors: Linda Dong”, 2025-2026
#	Asset manager	% of shares outstanding
1	BlackRock	4.11%
2	Vanguard	3.86%
3	Fidelity	2.04%
4	Columbia Threadneedle	1.79%
5	Charles Schwab	1.43%
6	TIAA	0.51%
7	PIMCO	0.44%
8	Nationwide	0.27%
9	Dimensional	0.25%
10	American Century	0.19%

Institutional-manager reports: top Fulgent Genetics, Inc. shareholders by shares voted on “To approve, on an advisory basis, compensation awarded to the Company's named executive…”, 2025-2026
#	Asset manager	% of shares outstanding
1	RTW INVESTMENTS, LP	4.54%
2	BlackRock	3.88%
3	ACADIAN ASSET MANAGEMENT LLC	2.65%
4	GEODE CAPITAL MANAGEMENT, LLC	1.96%
5	State Street	1.46%
6	Connor, Clark & Lunn Investment Management Ltd.	0.63%
7	JACOBS LEVY EQUITY MANAGEMENT, INC	0.58%
8	Vanguard	0.55%
9	Peapod Lane Capital LLC	0.51%
10	Nuveen	0.51%

Reported Fulgent Genetics, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Fulgent Genetics, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
Ming Hsieh	31.24%	13D
BlackRock	9.77%	13F
Barclays PLC	8.23%	DEF14A
Vanguard Group	4.44%	13F
Hanlin Gao, M.D., Ph.D., D.A.B.M.G., F.A.C.M.G.	3.28%	DEF14A
Integrated Core Strategies (US) LLC	3.23%	13G
Dimensional Fund Advisors	2.36%	13F
Geode Capital	2.06%	13F
State Street	1.86%	13F
D.E. Shaw	1.71%	13F

Percentages above are of 28,400,623 shares outstanding, as reported by Fulgent Genetics, Inc. on its Form 10-Q dated April 27, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Fulgent Genetics, Inc.’s 10-Q dated April 27, 2026. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At Fulgent Genetics, Inc.'s shareholder meeting held May 14, 2026, in the 2025-2026 proxy season, 210 asset managers reported how they voted on 7 ballot items in their SEC Form N-PX filings, covering 1,450 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, compensation awarded to the Company's named executive… — FOR was 89% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Fulgent Genetics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 14, 2026.

Fulgent Genetics, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.